171 related articles for article (PubMed ID: 33105866)
1. Fluorescent Dye Labeling Changes the Biodistribution of Tumor-Targeted Nanoparticles.
Álamo P; Pallarès V; Céspedes MV; Falgàs A; Sanchez JM; Serna N; Sánchez-García L; Voltà-Duràn E; Morris GA; Sánchez-Chardi A; Casanova I; Mangues R; Vazquez E; Villaverde A; Unzueta U
Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33105866
[TBL] [Abstract][Full Text] [Related]
2. Rational engineering of a human GFP-like protein scaffold for humanized targeted nanomedicines.
Álamo P; Cedano J; Conchillo-Sole O; Cano-Garrido O; Alba-Castellon L; Serna N; Aviñó A; Carrasco-Diaz LM; Sánchez-Chardi A; Martinez-Torró C; Gallardo A; Cano M; Eritja R; Villaverde A; Mangues R; Vazquez E; Unzueta U
Acta Biomater; 2021 Aug; 130():211-222. PubMed ID: 34116228
[TBL] [Abstract][Full Text] [Related]
3. Cancer-specific uptake of a liganded protein nanocarrier targeting aggressive CXCR4
Céspedes MV; Unzueta U; Álamo P; Gallardo A; Sala R; Casanova I; Pavón MA; Mangues MA; Trías M; López-Pousa A; Villaverde A; Vázquez E; Mangues R
Nanomedicine; 2016 Oct; 12(7):1987-1996. PubMed ID: 27085904
[TBL] [Abstract][Full Text] [Related]
4. Selective delivery of T22-PE24-H6 to CXCR4
Falgàs A; Pallarès V; Serna N; Sánchez-García L; Sierra J; Gallardo A; Alba-Castellón L; Álamo P; Unzueta U; Villaverde A; Vázquez E; Mangues R; Casanova I
Theranostics; 2020; 10(12):5169-5180. PubMed ID: 32373205
[No Abstract] [Full Text] [Related]
5. Collaborative membrane activity and receptor-dependent tumor cell targeting for precise nanoparticle delivery in CXCR4
Sala R; Sánchez-García L; Serna N; Céspedes MV; Casanova I; Roldán M; Sánchez-Chardi A; Unzueta U; Vázquez E; Mangues R; Villaverde A
Acta Biomater; 2019 Nov; 99():426-432. PubMed ID: 31494293
[TBL] [Abstract][Full Text] [Related]
6. CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinoma.
Rioja-Blanco E; Arroyo-Solera I; Álamo P; Casanova I; Gallardo A; Unzueta U; Serna N; Sánchez-García L; Quer M; Villaverde A; Vázquez E; León X; Alba-Castellón L; Mangues R
J Exp Clin Cancer Res; 2022 Feb; 41(1):49. PubMed ID: 35120582
[TBL] [Abstract][Full Text] [Related]
7. Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4
Rioja-Blanco E; Arroyo-Solera I; Álamo P; Casanova I; Gallardo A; Unzueta U; Serna N; Sánchez-García L; Quer M; Villaverde A; Vázquez E; Mangues R; Alba-Castellón L; León X
Acta Pharm Sin B; 2022 May; 12(5):2578-2591. PubMed ID: 35646535
[TBL] [Abstract][Full Text] [Related]
8. Antineoplastic effect of a diphtheria toxin-based nanoparticle targeting acute myeloid leukemia cells overexpressing CXCR4.
Pallarès V; Núñez Y; Sánchez-García L; Falgàs A; Serna N; Unzueta U; Gallardo A; Alba-Castellón L; Álamo P; Sierra J; Villaverde A; Vázquez E; Casanova I; Mangues R
J Control Release; 2021 Jul; 335():117-129. PubMed ID: 34004204
[TBL] [Abstract][Full Text] [Related]
9. A diphtheria toxin-based nanoparticle achieves specific cytotoxic effect on CXCR4
Falgàs A; Garcia-León A; Núñez Y; Serna N; Sánchez-Garcia L; Unzueta U; Voltà-Durán E; Aragó M; Álamo P; Alba-Castellón L; Sierra J; Gallardo A; Villaverde A; Vázquez E; Mangues R; Casanova I
Biomed Pharmacother; 2022 Jun; 150():112940. PubMed ID: 35421785
[TBL] [Abstract][Full Text] [Related]
10. T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo.
Núñez Y; Garcia-León A; Falgàs A; Serna N; Sánchez-García L; Garrido A; Sierra J; Gallardo A; Unzueta U; Vázquez E; Villaverde A; Mangues R; Casanova I
Pharmaceutics; 2023 Feb; 15(3):. PubMed ID: 36986589
[TBL] [Abstract][Full Text] [Related]
11. Selective CXCR4
Díaz R; Pallarès V; Cano-Garrido O; Serna N; Sánchez-García L; Falgàs A; Pesarrodona M; Unzueta U; Sánchez-Chardi A; Sánchez JM; Casanova I; Vázquez E; Mangues R; Villaverde A
Small; 2018 Jun; 14(26):e1800665. PubMed ID: 29845742
[TBL] [Abstract][Full Text] [Related]
12. A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse Model.
Rioja-Blanco E; Gallardo A; Arroyo-Solera I; Álamo P; Casanova I; Unzueta U; Serna N; Sánchez-García L; Quer M; Villaverde A; Vázquez E; León X; Alba-Castellón L; Mangues R
Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456719
[TBL] [Abstract][Full Text] [Related]
13. Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models.
Medina-Gutiérrez E; García-León A; Gallardo A; Álamo P; Alba-Castellón L; Unzueta U; Villaverde A; Vázquez E; Casanova I; Mangues R
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612081
[TBL] [Abstract][Full Text] [Related]
14. Selective depletion of metastatic stem cells as therapy for human colorectal cancer.
Céspedes MV; Unzueta U; Aviñó A; Gallardo A; Álamo P; Sala R; Sánchez-Chardi A; Casanova I; Mangues MA; Lopez-Pousa A; Eritja R; Villaverde A; Vázquez E; Mangues R
EMBO Mol Med; 2018 Oct; 10(10):. PubMed ID: 30190334
[TBL] [Abstract][Full Text] [Related]
15. Novel Endometrial Cancer Models Using Sensitive Metastasis Tracing for CXCR4-Targeted Therapy in Advanced Disease.
Medina-Gutiérrez E; Céspedes MV; Gallardo A; Rioja-Blanco E; Pavón MÀ; Asensio-Puig L; Farré L; Alba-Castellón L; Unzueta U; Villaverde A; Vázquez E; Casanova I; Mangues R
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884987
[TBL] [Abstract][Full Text] [Related]
16. Intracellular CXCR4⁺ cell targeting with T22-empowered protein-only nanoparticles.
Unzueta U; Céspedes MV; Ferrer-Miralles N; Casanova I; Cedano J; Corchero JL; Domingo-Espín J; Villaverde A; Mangues R; Vázquez E
Int J Nanomedicine; 2012; 7():4533-44. PubMed ID: 22923991
[TBL] [Abstract][Full Text] [Related]
17. Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4
Cano-Garrido O; Álamo P; Sánchez-García L; Falgàs A; Sánchez-Chardi A; Serna N; Parladé E; Unzueta U; Roldán M; Voltà-Durán E; Casanova I; Villaverde A; Mangues R; Vázquez E
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34208189
[TBL] [Abstract][Full Text] [Related]
18. High-precision targeting and destruction of cancer-associated PDGFR-β
Voltà-Durán E; Alba-Castellón L; Serna N; Casanova I; López-Laguna H; Gallardo A; Sánchez-Chardi A; Villaverde A; Unzueta U; Vázquez E; Mangues R
Acta Biomater; 2023 Oct; 170():543-555. PubMed ID: 37683965
[TBL] [Abstract][Full Text] [Related]
19. Selection of fluorescent dye for tracking biodistribution of paclitaxel in live imaging.
Shuai Q; Zhao G; Zhang X; Yu B; Lee RJ; Su WK
Colloids Surf B Biointerfaces; 2019 Sep; 181():872-878. PubMed ID: 31382335
[TBL] [Abstract][Full Text] [Related]
20. Recruiting potent membrane penetrability in tumor cell-targeted protein-only nanoparticles.
Serna N; Sánchez JM; Unzueta U; Sánchez-García L; Sánchez-Chardi A; Mangues R; Vázquez E; Villaverde A
Nanotechnology; 2019 Mar; 30(11):115101. PubMed ID: 30561375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
